ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 166 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.89 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $605,000 | -27.5% | 97,347 | -29.4% | 0.07% | -16.0% |
| Q1 2017 | $834,000 | +284.3% | 137,824 | +240.5% | 0.08% | +170.0% |
| Q4 2016 | $217,000 | -85.0% | 40,477 | -84.7% | 0.03% | -84.4% |
| Q2 2016 | $1,449,000 | -65.0% | 263,878 | -52.7% | 0.19% | -61.6% |
| Q1 2016 | $4,142,000 | +397.2% | 558,204 | +457.1% | 0.50% | +380.8% |
| Q4 2015 | $833,000 | +54.0% | 100,194 | +67.0% | 0.10% | +40.5% |
| Q3 2015 | $541,000 | -30.8% | 60,000 | -8.0% | 0.07% | -44.4% |
| Q2 2015 | $782,000 | +134.8% | 65,200 | +110.6% | 0.13% | +49.4% |
| Q1 2015 | $333,000 | – | 30,956 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
| MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
| MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
| Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
| Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
| Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
| tru Independence LLC | 213,712 | $701,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
| Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |